Lord, Abbett & Co’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-439,098	Closed	-$47.1M	–	601
2023 Q1	$47.1M	Buy	439,098 +136,040	+45%	+$14.6M	0.17%	193
2022 Q4	$33.3M	Buy	+303,058	New	+$33.3M	0.12%	249